BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26724721)

  • 1. Efficient CRISPR/Cas9-Based Genome Engineering in Human Pluripotent Stem Cells.
    Kime C; Mandegar MA; Srivastava D; Yamanaka S; Conklin BR; Rand TA
    Curr Protoc Hum Genet; 2016 Jan; 88():21.4.1-21.4.23. PubMed ID: 26724721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium.
    Soh CL; Huangfu D
    Methods Mol Biol; 2017; 1498():57-78. PubMed ID: 27709569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing in Human Pluripotent Stem Cells.
    Carlson-Stevermer J; Saha K
    Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.
    Li M; Suzuki K; Kim NY; Liu GH; Izpisua Belmonte JC
    J Biol Chem; 2014 Feb; 289(8):4594-9. PubMed ID: 24362028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CRISPR/Cas9 system for plant genome editing and beyond.
    Bortesi L; Fischer R
    Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
    Zhu Z; González F; Huangfu D
    Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System.
    Xue H; Wu J; Li S; Rao MS; Liu Y
    Methods Mol Biol; 2016; 1307():173-90. PubMed ID: 24615461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origins of Programmable Nucleases for Genome Engineering.
    Chandrasegaran S; Carroll D
    J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
    Hendriks WT; Jiang X; Daheron L; Cowan CA
    Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.
    Hou Z; Zhang Y; Propson NE; Howden SE; Chu LF; Sontheimer EJ; Thomson JA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15644-9. PubMed ID: 23940360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation.
    Blair JD; Bateup HS; Hockemeyer DF
    J Vis Exp; 2016 Feb; (108):e53583. PubMed ID: 26863600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions.
    Hendriks WT; Warren CR; Cowan CA
    Cell Stem Cell; 2016 Jan; 18(1):53-65. PubMed ID: 26748756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing in Human Cells Using CRISPR/Cas Nucleases.
    Wyvekens N; Tsai SQ; Joung JK
    Curr Protoc Mol Biol; 2015 Oct; 112():31.3.1-31.3.18. PubMed ID: 26423589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
    Merkert S; Martin U
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.